Unicycive Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Unicycive Therapeutics

Access the complete profile.

Unicycive Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	4300 El Camino Real Suite #210 Los Altos, CA 94022

Note: Revenues for privately held companies are statistical evaluations.


Unicycive Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Unicycive Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Unicycive Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Unicycive Therapeutics Annual Revenue and Growth Rate

Unicycive Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Unicycive Therapeutics's revenues are gauged from an analysis of company filings.

Unicycive Therapeutics's Income Statement (based on Industry Averages)

Unicycive Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Unicycive Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 20, 2024	25	100%	$50 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Unicycive Therapeutics is developing and marketing. Unicycive Therapeutics doesn't have any recent trademark applications, indicating Unicycive Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RENQYRO Pharmaceutical compositions containing lanthanum used to decrease the serum phosphate levels in humans and other mammals with hyperphosphatemia	10/16/2023
KONQYRO Pharmaceutical compositions containing lanthanum used to decrease the serum phosphate levels in humans and other mammals with hyperphosphatemia	10/16/2023
RENAZORB PHARMACEUTICAL COMPOSITIONS CONTAINING LANTHANUM USED TO DECREASE THE SERUM PHOSPHATE LEVELS IN HUMANS AND OTHER MAMMALS WITH HYPERPHOSPHATEMIA	07/25/2011

See all trademarks and details in the Full Report.

Market Share of Unicycive Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Unicycive Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Unicycive Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EMERALD THERAPEUTICS	South San Francisco, CA	100
PHARMACYCLICS	Sunnyvale, CA	59
ALTOS LABS	Redwood City, CA	39
NURO	Mountain View, CA	30
SRI INTERNATIONAL	Menlo Park, CA	27
EXPONENT	Menlo Park, CA	21

Other Companies at 4300 El Camino Real, Los Altos CA

Company	Headquarters	Revenue ($ MM)
BERMAN SKIN INSTITUTE MEDICAL GROUP	Los Altos, CA	100
RETROTOPE	Los Altos, CA	80
HAMMERSPACE	Los Altos, CA	53
TRUE CIRCUITS	Los Altos, CA	8
TOPICA PHARMACEUTICALS	Los Altos, CA	0

Future Competition: Unicycive Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Unicycive Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)